Enrique M. Ocio, David Vilanova, Peter Atadja, Patricia Maiso, Edvan Crusoe, Diego Fernández-Lázaro, Mercedes Garayoa, Laura San-Segundo, Teresa Hernández-Iglesias, Enrique de Álava, Wenlin Shao, Yung-Mae Yao, Atanasio Pandiella, and Jesús F. San-Miguel. 2010. “In Vitro and in Vivo Rationale for the Triple Combination of Panobinostat (LBH589) and Dexamethasone With Either Bortezomib or Lenalidomide in Multiple Myeloma”. Haematologica 95 (5). Pavia, Italy, 794-803. https://doi.org/10.3324/haematol.2009.015495.